Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer

Abstract

This study aimed to evaluate the safety of neoadjuvant gemcitabine combination radiation therapy in the treatment of biliary tract cancer and to investigate the pathological effects of chemoradiation therapy and its impact on survival. Chemoradiation therapy entailed three cycles of full dose of gemcitabine (1000 mg/m2 at days 1, 8, and 15, every 4 weeks… (More)
DOI: 10.1007/s00280-015-2908-3

Topics

6 Figures and Tables